Increased serum levels of transforming growth factor β-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis
- 1 July 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 84 (3) , 381-386
- https://doi.org/10.1111/j.1365-2141.1993.tb03090.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome.The Journal of Experimental Medicine, 1991
- The role of transforming growth factor-beta in hematopoiesis. A reviewLeukemia Research, 1991
- Capture Immunoassays Specific for TGFβ1 and TGFβ2: Use in Pharmacokinetic StudiesAnnals of the New York Academy of Sciences, 1990
- The TGF-β family of growth and differentiation factorsCell, 1987
- Transforming Growth Factor-β: Biological Function and Chemical StructureScience, 1986
- Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.Proceedings of the National Academy of Sciences, 1986
- Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth FactorScience, 1984
- Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic PurpuraAnnals of Internal Medicine, 1984
- Normal embryo fibroblasts release transforming growth factors in a latent formJournal of Cellular Physiology, 1984
- HqMOLYTIC-URqMIC SYNDROME: DEFICIENCY OF PLASMA FACTOR(S) REGULATING PROSTACYCLIN ACTIVITY?The Lancet, 1978